Angelica Hanna

Angelica Hanna

Auto-generated profile, based on publicly available information

Angelica Hanna

Temerty Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2025 in Journal of Cataract & Refractive Surgery
Verified
Journal Article
Closed access
AHAngelica Md(C) Hanna
Angelica Md(C) Hanna
DMDiana Lucia Martinez
Diana Lucia Martinez
MPMarko Popovic
Marko Popovic
IAIqbal Md Ike K Ahmed
Iqbal Md Ike K Ahmed
JTJoshua Md Teichman
Joshua Md Teichman
Topic: To examine the association between virtual postoperative follow-up care and patient outcomes after cataract surgery. Clinical Relevance: Cataract surgery is a safe and commonly performed surgery. Follow-up visits are used to monitor for complications. It is uncertain whether virtual follow-up provides a safe alternative to in-person review. Methods: MEDLINE, Embase, and CINAHL were searched from inception to October 2023 for relevant articles containing original data. Studies that (1) included patients who were seen in a virtual follow-up (ie, telephone or video call) for postoperative appointments after cataract surgery and (2) reported patient outcomes were included. Risk of bias (RoB) was assessed using the Newcastle-Ottawa and RoB2 assessment tools. Descriptive statistics were used to summarize findings. The review was registered in PROSPERO (registration number, CRD42023477207), and PRISMA guidelines were followed. Results: The search yielded 1710 records with 7 studies included in this review. The 7 studies reported on 2113 cataract surgeries in 1994 patients. The studies ranged between 2004 and 2020. Most of the studies (5/7) included only patients with uneventful cataract surgery. Virtual follow-ups were all conducted by telephone. The follow-up calls were made at varying timepoints including postoperative day 1 (n = 3), day 7 (n = 2), and day 14 (n = 1). 2 observational studies directly compared patients who had a telephone follow-up with a control group who had an in-person follow-up. There were no significant differences in complication rates (P = .22) or visual acuity (P = .28) between these follow-up groups. None of the studies reported serious adverse outcomes from replacing in-person follow-up with telephone follow-up. One study used virtual follow-up in conjunction with in-person visits for elderly patients and found that additional telephone follow-up was associated with decreased surgical recovery time and decreased patient anxiety. 3 studies reported on patient perceptions about telephone follow-up. A common theme was that patients preferred telephone reviews and found them to be more convenient than in-person follow-up. Conclusions: For patients with uneventful cataract surgery, virtual follow-ups seem to be a safe alternative to in-person visits and were preferred by patients. These conclusions are preliminary given the limited literature base, and further study is needed.

1 August 2025 in Journal of Cataract & Refractive Surgery
Verified
Journal Article
Closed access
AHAngelica Bsc Hanna
Angelica Bsc Hanna
JAJames Jacob Armstrong
James Jacob Armstrong
EKEfstathia Kiatos-Tsioros
Efstathia Kiatos-Tsioros
GRGuillermo Rocha
Guillermo Rocha
CHCindy M.L. Hutnik
Cindy M.L. Hutnik
IAIqbal Ike K. Ahmed
Iqbal Ike K. Ahmed
Topic: This review assesses the effectiveness of intravenous (IV) sedation compared with non-IV sedation for routine cataract surgery. Clinical Relevance: Cataract surgery is a safe and routinely performed surgery. Sedation practices vary, with centers providing IV, oral, or no sedation for surgery. Improving sedation practices may have significant implications for patient safety, patient experience, and health system efficiency. Methods: MEDLINE, Embase, Cochrane Library, BIOSIS, Web of Science, and CINAHL were searched from inception to July 2024 for relevant articles containing original data. Randomized controlled trials that compared IV with oral or no sedation and (1) used a validated pain scale to report on pain or (2) reported on perioperative complications were included. A random-effects meta-analysis was conducted. Odds ratios (ORs), standard mean differences (SMDs), 95% CIs, and I 2 statistics were reported. The review was registered in PROSPERO (CRD42024582495), and PRISMA guidelines were followed. Results: 12 randomized controlled trials including 1130 patients were included in the meta-analysis. IV sedation was associated with significantly decreased pain compared with no sedation (SMD, −0.98; 95% CI, −1.68 to −0.29). Comparing IV and oral sedation, however, there was no difference in patient-reported pain (SMD, −0.54; 95% CI, −1.60 to 0.52). Analysis of intraoperative complications showed that there was no significant difference in complications between patients receiving IV and oral sedation (OR, 0.68; 95% CI, 0.27-1.73). Conclusions: For routine cataract surgery, IV sedation was associated with less pain than no sedation, but oral and IV sedation provided comparable pain control. Perioperative complications occur at similar rates regardless of sedation modality. These findings may help to inform sedation practices for cataract surgery.

19 February 2025 in Canadian Journal of Ophthalmology
Verified
Journal Article
Open access
AHAngelica Hanna
Angelica Hanna
DMDiana Lucia Martinez
Diana Lucia Martinez
MSMatthew B Schlenker
Matthew B Schlenker
IAIqbal I.K. Ahmed
Iqbal I.K. Ahmed
Despite a universal health care system, access to vision care in Canada is not necessarily equally accessible to all patients. The purpose of this review was to explore the association between socioeconomic status (SES) and vision care utilization in Canada. Medline, Embase, CINAHL, and Cochrane were searched from inception to January 2024 for relevant articles containing original data. Studies that explored the association between SES and vision care utilization in Canadian patients were included. Risk of bias was assessed using the Newcastle-Ottawa and AXIS assessment tools. Descriptive statistics were used to summarize findings. The review was registered in PROSPERO (registration number: CRD42024502482) and followed PRISMA guidelines. The search yielded 2,670 records with 23 studies included in this review. The included studies covered all provinces and ranged in date between 1985 and 2022. The included studies explored the relationship between SES and utilization of ophthalmic care, optometric care, or both. Overall, 17 of the 23 studies found that patients of lower SES were significantly more likely to have decreased usage of vision care. Decreased vision care utilization was found for all optometry, ophthalmology care, and diabetic retinopathy screening, as well as for patients of all ages, and in all provinces. Low socioeconomic status was consistently associated with decreased vision care utilization for patients of all ages. Efforts are required to increase accessibility to vision care for low-income individuals and to improve health equity.

15 November 2025 in Canadian Journal of Ophthalmology
Verified
Journal Article
Open access
CZChris Zajner
Chris Zajner
AHAngelica Hanna
Angelica Hanna
MZMichele Zaman
Michele Zaman
LBLulu L.C.D. Bursztyn
Lulu L.C.D. Bursztyn
While radiographic measurements of orbital structures are used to both diagnose thyroid eye disease (TED) and assess treatment response, the specific extraocular muscle (EOM) changes in TED have not been established. This study aims to systematically review and analyze the difference in EOM sizes in TED patients. Systematic review. The full protocol was registered on PROSPERO (42024566103). The electronic databases EMBASE, Web of Science, and OVID MEDLINE were searched from inception to June 5, 2024, using keywords related to TED and EOMs. Studies were included if they reported EOM measurements in both a TED group and a control group. Data were analyzed using random-effects model meta-analyses, with subgroup analyses based on EOM measurement parameters (i.e., diameter, cross-sectional area, volume). Twenty-three studies were identified, which together included a total of 2 708 orbits with TED and 1 221 control orbits. Eleven studies were retrospective cohort studies, and 12 were prospective cohort studies. Meta-analysis revealed a mean difference between TED patients and controls in EOM diameter for the inferior rectus of 1.9 mm (95% confidence interval: 1.4-2.3; p < 0.01), medial rectus 1.6 mm (95% CI: 1.1-2.0; p < 0.01), lateral rectus 0.89 mm (95% CI: 0.4-1.4; p < 0.01), and superior rectus 1.3 mm (95% CI: 1.0-1.6; p < 0.01). The mean difference between TED patients and controls in EOM volume for the inferior rectus was 515 mm3 (95% CI: 230-801; p < 0.01), superior rectus was 609 mm3 (95% CI: 327-891; p < 0.01), medial rectus was 551 mm3 (95% CI: 293-810; p < 0.01), and lateral rectus was 288 mm3 (95% CI: 182-393; p < 0.01). Across studies, there is an apparent enlargement of the inferior rectus in TED compared to controls, but the relative extent of involvement of the medial rectus, superior rectus, and lateral rectus is less consistent.

8 October 2025 in Canadian Journal of Ophthalmology
Verified
Journal Article
Open access
AHAngelica Hanna
Angelica Hanna
DMDiana Lucia Martinez
Diana Lucia Martinez
IAIqbal I.K. Ahmed
Iqbal I.K. Ahmed
MSMatthew B. Schlenker
Matthew B. Schlenker
Socioeconomic status (SES) is a known social determinant of general health. The purpose of this review was to explore the association between SES and visual impairment and ocular disease in Canada. Medline, Embase, CINAHL, and Cochrane were searched from inception to October 2024 for studies that explored the association between SES and visual impairment or ocular disease in Canadian patients. Descriptive statistics were used to summarize the findings. The review was registered in PROSPERO (registration number, CRD42024502490). Twenty-eight studies were included in the review. The included studies covered all provinces and territories and included patients of all ages. Fourteen of the included studies explored the relationship between SES and visual impairment. Eleven of the 14 studies found that patients of lower SES were more likely to have visual impairment, while 3 studies found no significant differences. Fourteen studies have explored the association between SES and various ocular diseases. Glaucoma, macular diseases, diabetic retinopathy, and idiopathic intracranial hypertension were all noted to be of higher prevalence in patients with lower income levels. Patients of lower SES were at the greatest risk of having more severe cataracts (p = 0.001). Among patients with diabetes, those in the lowest SES quintile were at an increased risk of ophthalmological complications compared to higher earners. SES is a determinant of ocular health in Canada. Higher rates of visual impairment and ocular diseases are associated with lower patient socioeconomic status. Efforts are required to mitigate this disparity and improve health equity.

10 January 2025 in Research Square
Verified
Preprint
Open access
PDF file
RSRahul Sharma
Rahul Sharma
AHAngelica Hanna
Angelica Hanna
ASAswen Sriranganathan
Aswen Sriranganathan
PKPeter Kertes
Peter Kertes
GYGary Yau
Gary Yau
Objectives To explore the evidence on the use of anti-vascular endothelial growth factor (anti-VEGF) therapy for the treatment of peripapillary choroidal neovascular membrane (pCNVM). Methods Medline, Embase and the Cumulative Index to Nursing and Allied Health Literature (CINAHL) were searched between January 2000 and December 2024 for relevant articles that used anti-VEGF therapy to treat pCNVM of any origin. This review followed PRISMA guidelines and was prospectively registered (PROSPERO registration number CRD42024551949). Results Ten studies reporting on 269 eyes were included. Eight studies used a pro re nata (PRN) strategy, 1 study used a loading phase followed by an as-needed phase and 1 study used a fixed schedule strategy. There was a mean of 7 injections required. Eight studies reported improvements in best corrected visual acuity (BCVA) at final follow-up following treatment. The mean logarithm of the minimum angle of resolution (logMAR) change was 0.092, or approximately one line Snellen improvement. Two studies reported on macular thickness, and one reported on choroidal thickness after treatment, all of which noted decreased thickness at final follow-up. No significant complications were reported. Conclusions For patients with pCNVM of various etiologies, anti-VEGF injections using any treatment strategy, including conservative management with a PRN approach, seems to be a safe and effective therapy associated with improved visual acuity.